Sanjay Jagannath is a Gastroenterology physician affiliated with Wake Research. OpenAlex indexes 129 publications with 6,708 citations (h-index 31); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2601 Lake Dr
Raleigh, NC 276076688
Telephone
919-783-4888Registry record last updated 19 Nov 2015.
Clinical trials
- Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal Cancer or Gastroesophageal Junction Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202515 payments
- Janssen Biotech, Inc.Program year20254 payments
- PFIZER INC.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
86.7%Dopamine-2 Receptor Antagonist25%Metoclopramide Hcl100%Part D≥263 patientsProton pump inhibitor20.1%Pantoprazole Sodium58%Omeprazole29%Rabeprazole Sodium8%Dexlansoprazole Dr6%Part D<11 patients+ 8 more classes in this area
Blood & clotting
11.1%Solutions for parenteral nutrition11.1%Peg 3350-Electrolyte100%Part D≥117 patientsCancer & immunology
2.2%TNF inhibitor2.2%Humira Pen52%Humira(Cf) Pen48%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Comparative Evaluation of Early Stent Occlusion Among Biliary Conventional Versus Wing Stents
Digestive Diseases and Sciences
2012 - Autoimmune pancreatitis: Current diagnostic criteria are suboptimal
Journal of Gastroenterology and Hepatology
2011 - Endoscopic Ultrasound and Fine-needle Aspiration for the Diagnosis of Hepatocellular Carcinoma
Clinics in Liver Disease
2010 - Giant Multi-Polypoid Liposarcoma of the Esophagus: An Atypical Presentation
The Annals of Thoracic Surgery
2010
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”